Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more
PRINCETON, N.J., June 20, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the โCompanyโ or โSonnetโ), a clinical-stage company developing targeted immunotherapeutic...
Sonnet discovered and characterized a modified version of Interleukin-18 (IL-18Binding Protein Resistant or IL-18BPR) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with...
PRINCETON, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.022 | -2.39130434783 | 0.92 | 0.959999 | 0.8711 | 45230 | 0.92173343 | CS |
4 | -0.742 | -45.243902439 | 1.64 | 2 | 0.8705 | 66332 | 1.13499182 | CS |
12 | -1.052 | -53.9487179487 | 1.95 | 2.1 | 0.8705 | 35892 | 1.37157068 | CS |
26 | -0.842 | -48.3908045977 | 1.74 | 2.3399 | 0.8705 | 69950 | 1.80721153 | CS |
52 | -10.542 | -92.1503496503 | 11.44 | 12.1 | 0.8705 | 350515 | 6.96095863 | CS |
156 | -464.182 | -99.8069149394 | 465.08 | 637.56 | 0.8705 | 2844865 | 137.20816223 | CS |
260 | -1914.862 | -99.9531256525 | 1915.76 | 4989.6 | 0.8705 | 2500683 | 329.49133607 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.